GLP-1 & MetabolicCAS 2381089-83-2

Retatrutide

Retatrutide is a synthetic investigational peptide developed as a multi-pathway agonist, representing the next generation of metabolic research compounds. It activates multiple target receptor subtypes for broad systemic effects studied in preclinical models.

Wholesale Pricing

Available Doses & Tiered Pricing

Retatrutide 10mg

Save 43%
  • 50 vials$30.00 / vial
  • 100 vials$23.00 / vial
  • 250 vials$20.00 / vial
  • 500 vials★ Best Value$17.00 / vial
Get Pricing for 10mg

Retatrutide 30mg

Save 33%
  • 50 vials$45.00 / vial
  • 100 vials$40.00 / vial
  • 250 vials$35.00 / vial
  • 500 vials★ Best Value$30.00 / vial
Get Pricing for 30mg

Retatrutide 60mg

Save 29%
  • 50 vials$72.00 / vial
  • 100 vials$65.00 / vial
  • 250 vials$58.00 / vial
  • 500 vials★ Best Value$51.00 / vial
Get Pricing for 60mg

Overview

Retatrutide is a synthetic investigational peptide developed as a multi-pathway agonist, representing the next generation of metabolic research compounds. It activates multiple target receptor subtypes for broad systemic effects studied in preclinical models.

History

Builds on decades of single- and dual-agonist research; uniquely integrates three pathway targets.

Key Areas of Research

  • Receptor binding and cascades
  • Pathway subtypes and modulation
  • Vascular lipid pathways
  • Multi-system signaling

References

  1. Jastreboff A.M. et al. (2023). Triple-hormone-receptor agonist retatrutide for obesity. NEJM 389:514–526.
  2. Coskun T. et al. (2022). LY3437943 triple agonist. Mol Metabol 69:101470.

Research Use Only

All products are intended solely for laboratory research purposes and are not for human or animal consumption. Must be handled by qualified professionals.